ClinicalTrials.Veeva

Menu

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach (OERS)

P

Professor Michael Bourke

Status

Completed

Conditions

Adenoma, Villous

Treatments

Procedure: Endoscopic Mucosal Resection

Study type

Observational

Funder types

Other

Identifiers

NCT02306707
HREC2014/5/4.1 (3970)

Details and patient eligibility

About

A patient referred to have a lesion in the stomach removed. The aims of this study are to collect information on the technique of endoscopic removal of such lesions. By collecting information on a large number of patients undergoing this procedure the investigators can determine the best ways of diagnosing and removing these lesions safely and effectively.

Enrollment

200 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stomach lesion > 10mm
  • Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
  • Aged 18 years or older

Exclusion criteria

  • Lesion less than 10mm
  • Stomach lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
  • Aged younger than 18 years

Trial design

200 participants in 1 patient group

Endoscopic Mucosal Resection
Description:
Patients who are referred for Endoscopic Mucosal Resection of Stomach Lesions will be included in this cohort.
Treatment:
Procedure: Endoscopic Mucosal Resection

Trial contacts and locations

1

Loading...

Central trial contact

Farzan F Bahin, MBBS; Kathleen Goodrick, BN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems